Patents by Inventor Tamim F. Braish

Tamim F. Braish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6316632
    Abstract: A process for preparing 2-phenyl-3-aminopyridine, and substituted phenyl derivatives and salts thereof.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: November 13, 2001
    Assignee: Pfizer Inc
    Inventors: Tamim F. Braish, Stephane Caron, Michael James Castaldi
  • Patent number: 5939550
    Abstract: A multi-step process for preparing a dipeptide derivative of 7-(6-amino-3-azabicyclo?3.1.0.!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1 ,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, in the form of a pharmaceutically acceptable acid addition salt is disclosed.
    Type: Grant
    Filed: March 11, 1998
    Date of Patent: August 17, 1999
    Assignee: Pfizer Inc.
    Inventors: Tamim F. Braish, Michael J. Castaldi, Harry A. Watson, Jr.
  • Patent number: 5929240
    Abstract: This invention relates to novel processes and intermediates for the preparation of pharmaceutically acceptable acid salts, of the formula
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: July 27, 1999
    Assignee: Pfizer Inc.
    Inventors: Tamim F. Braish, Darrell E. Fox, Timothy Norris, Peter R. Rose
  • Patent number: 5523413
    Abstract: 1S,4S and 1R,4R-2-Alkyl-2,5-diazabicyclo[2.2.1]-heptanes useful as intermediates in the synthesis of certain antibacterial quinolones, are prepared respectively, from trans-4-hydroxy-L-proline and trans-4-hydroxy-D-proline via multistep procedures.
    Type: Grant
    Filed: September 11, 1995
    Date of Patent: June 4, 1996
    Assignee: Pfizer Inc.
    Inventors: Tamim F. Braish, Darrell E. Fox
  • Patent number: 5475116
    Abstract: This invention relates to certain azabicyclo hexane intermediates and processes for making and using the azabicyclo hexane intermediates. The intermediates are useful in the synthesis of quinolone antibacterial agents.
    Type: Grant
    Filed: April 29, 1994
    Date of Patent: December 12, 1995
    Assignee: Pfizer Inc.
    Inventors: Katherine E. Brighty, Tamim F. Braish
  • Patent number: 5475117
    Abstract: 1S,4S and 1R,4R-2-Alkyl-2,5-diazabicyclo[2.2.1]heptanes useful as intermediates in the synthesis of certain antibacterial quinolones, are prepared respectively, from trans-4-hydroxy-L-proline and trans-4-hydroxy-D-proline via multistep procedures.
    Type: Grant
    Filed: September 6, 1994
    Date of Patent: December 12, 1995
    Assignee: Pfizer, Inc.
    Inventors: Tamim F. Braish, Darrell E. Fox
  • Patent number: 5436368
    Abstract: Compounds of the formula ##STR1## which are intermediates in the preparation of 4,5-difluoroanthranilic acid, an intermediate itself in the synthesis of quinolone antibacterials, and methods of preparing these intermediates.
    Type: Grant
    Filed: November 14, 1994
    Date of Patent: July 25, 1995
    Assignee: Pfizer Inc.
    Inventor: Tamim F. Braish
  • Patent number: 5371235
    Abstract: 1S,4S and 1R,4R-2-Alkyl-2,5-diazabicyclo[2.2.1]heptanes useful as intermediates in the synthesis of certain antibacterial quinolones, are prepared respectively, from trans-4-hydroxy-L-proline and trans-4-hydroxy-D-proline via multistep procedures.
    Type: Grant
    Filed: June 10, 1992
    Date of Patent: December 6, 1994
    Assignee: Pfizer Inc.
    Inventors: Tamim F. Braish, Darrell E. Fox
  • Patent number: 5256791
    Abstract: This invention relates to novel processes for preparing compounds of the formulae ##STR1## wherein R and X defined as below. Compounds of the formulae VII are useful as intermediates in the syntheses of azabicyclo quinoline carboxylic acids having antibacterial activity. This invention also relates to certain novel intermediates in the syntheses such antibiotics.
    Type: Grant
    Filed: March 2, 1992
    Date of Patent: October 26, 1993
    Assignee: Pfizer Inc.
    Inventor: Tamim F. Braish
  • Patent number: 5196548
    Abstract: Diazabicyclo[2.2.1]heptane intermediates are prepared from 4-hydroxy-L-proline in a five step procedure, or from allo-4-hydroxy-D-proline, through a novel 2-(C.sub.1 -C.sub.6)alkyl-5-substituted-2,5-diazabicyclo[2.2.1]heptane intermediate. The diazabicycloheptanes are of use in the preparation of antibiotic quinolones.
    Type: Grant
    Filed: July 2, 1992
    Date of Patent: March 23, 1993
    Assignee: Pfizer Inc.
    Inventors: Tamim F. Braish, Darrell E. Fox
  • Patent number: 5153350
    Abstract: A process for preparing 3,4,6-trifluorophthalonitrile from 3,4,5,6-tetrachlorophthalonitrile comprising the sequential steps of reductively dechlorinating the tetrachlorophthalonitrile, in the presence of a metal in an aqueous acidic medium, to produce 3,4,6-trichlorophthalonitrile and then subjecting the trichlorophthalonitrile to a chlorine-fluorine exchange by reaction with a fluoride source in a polar aprotic solvent.
    Type: Grant
    Filed: May 16, 1991
    Date of Patent: October 6, 1992
    Inventor: Tamim F. Braish
  • Patent number: 5095121
    Abstract: 1S,4S and 1R,4R-2-Alkyl-2,5-diazabicyclo[2.2.1]heptanes useful as intermediates in the synthesis of certain antibacterial quinolones, are prepared respectively, from trans-4-hydroxy-L-proline and trans-4-hydroxy-D-proline via multistep procedures.
    Type: Grant
    Filed: January 8, 1991
    Date of Patent: March 10, 1992
    Assignee: Pfizer Inc
    Inventors: Tamim F. Braish, Darrell E. Fox
  • Patent number: 5082970
    Abstract: A novel process for converting trans-isomeric N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine to cis-isomeric N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine is disclosed. The process involves contacting trans-isomeric N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine, or a mixture of same with up to about an equal part by weight of the corresponding cis-isomer, with a basic equilibration agent like potassium tert.-butoxide in a reaction-inert polar organic solvent to ultimately afford a cis/trans-mixture wherein the amount of cis-amine present in said mixture achieves a constant value of about 2:1 on a weight-by-weight basis. The aforesaid resultant mixture is useful as an intermediate product that ultimately leads to pure cis-(1S) (4S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine (sertraline), which is a known antidepressant agent.
    Type: Grant
    Filed: March 6, 1991
    Date of Patent: January 21, 1992
    Assignee: Pfizer Inc.
    Inventor: Tamim F. Braish
  • Patent number: 5036153
    Abstract: (R,R)-2,5-Diazabicyclo[ 2.2.1]heptanes are prepared from a compound of the formula ##STR1## wherein X and R.sub.2 are as defined herein, by heating with tosylchloride in pyridine, reacting the formed compound of the formula ##STR2## with a C.sub.1 -C.sub.6 alkylamine or ammonia, and reducing or hydrolyzing the formed compound of the formula ##STR3## wherein R.sub.1 is hydrogen or C.sub.1 -C.sub.6 alkyl.
    Type: Grant
    Filed: October 18, 1989
    Date of Patent: July 30, 1991
    Inventors: Tamim F. Braish, Darrell E. Fox
  • Patent number: 5013839
    Abstract: 1S,4S and 1R,4R-2-alkyl-2,5-diazabicyclo[2.2.1]-heptanes useful as intermediates in the synthesis of certain antibacterial quinolones, are prepared respectively, from trans-4-hydroxy-L-proline and trans-4-hydroxy-D-proline via multistep procedures.
    Type: Grant
    Filed: December 21, 1989
    Date of Patent: May 7, 1991
    Assignee: Pfizer Inc.
    Inventors: Tamim F. Braish, Darrell E. Fox